Skip to main navigation Skip to search Skip to main content

WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed

  • Mary Y Wu
  • , Edward J Carr
  • , Ruth Harvey
  • , Harriet V Mears
  • , Svend Kjaer
  • , Hermaleigh Townsley
  • , Agnieszka Hobbs
  • , Martina Ragno
  • , Lou S Herman
  • , Lorin Adams
  • , Steve Gamblin
  • , Michael Howell
  • , Rupert Beale
  • , Michael Brown
  • , Bryan Williams
  • , Sonia Gandhi
  • , Charles Swanton
  • , Emma C Wall
  • , David L V Bauer*
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate (Academic Journal)

37 Citations (Scopus)

Abstract

[No abstract]
Original languageEnglish
Pages (from-to)2193-2196
Number of pages4
JournalThe Lancet
Volume400
Issue number10369
Early online date6 Oct 2022
DOIs
Publication statusPublished - 17 Dec 2022

Bibliographical note

Publisher copyright:
© 2022 Elsevier Ltd. All rights reserved.

Keywords

  • Humans
  • COVID-19
  • World Health Organization

Fingerprint

Dive into the research topics of 'WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed'. Together they form a unique fingerprint.

Cite this